×
Sign In
Accessibility Accessibility ToolBar Menu Arabic Search Menu
 
عمار منتصر المعايطه
• قسم الصيدلة التكنولوجية - عضو هيئة تدريس
• كلية الصيدلة - عميد
• مركز دراسات التنمية المستدامة والتكنولوجيا - مدير مركز

  • الدكـتوراة في صيدله من جامعة الملكة/بلفاست /بريطانيا, 2010
  • بكالوريوس في صيدله من الجامعه الاردنية, 2006

    Publications
  • Almaaytah, Ammar, Mei Zhou, Lei Wang, Tianbao Chen, Brian Walker, and Chris Shaw., "Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: Biochemical and functional characterization of natural peptides and a single site-substituted analo," Peptides, vol. 35, no. 2, pp. 291-299, 2012
  • Mukattash, Tareq L., Mohd Shara, Anan S. Jarab, Sayer I. Al Azzam, Ammar Almaaytah, and Yazid N. Al Hamarneh. , "Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 Jordanians," International Journal of Pharmacy Practice, vol. 20, no. 6, pp. 367-376, 2012
  • Al-Balas, Qosay, Mohammad Hassan, Buthina Al-Oudat, Hassan Alzoubi, Nizar Mhaidat, and Ammar Almaaytah, "Generation of the First Structure-Based Pharmacophore Model Containing a Selective "Zinc Binding Group" Feature to Identify Potential Glyoxalase-1 Inhibitors," Molecules, vol. 12, no. 17, pp. 13740-13758, 2012
  • Almaaytah, Ammar, Shadi Tarazi, Nizar Mhaidat, Qosay Al-Balas, and Tareq L. Mukattash, "Mauriporin, a Novel Cationic Alpha-Helical Peptide with Selective Cytotoxic Activity Against Prostate Cancer Cell Lines from the Venom of the Scorpion Androctonus mauritanicus," International Journal of Peptide Research and Therapeutics , vol. 19, no. 4, pp. 281-293, 2013
  • Al-Balas, Qosay A., Haneen A. Amawi, Mohammad A. Hassan, Amjad M. Qandil, Ammar M. Almaaytah, and Nizar M. Mhaidat., "Virtual Lead Identification of Farnesyltransferase Inhibitors Based on Ligand and Structure-Based Pharmacophore Techniques," Pharmaceuticals, vol. 6, no. 6, pp. 700-715,
  • Almaaytah, Ammar, and Qosay Albalas., "Scorpion venom peptides with no disulfide bridges: a review," Peptides, vol. 51, no. , pp. 35-45, 2014
  • Al-Balas, Qosay A., Munia F. Sowaileh, Mohammad A. Hassan, Amjad M. Qandil, Karem H. Alzoubi, Nizar M. Mhaidat, Ammar M. Almaaytah, and Omar F. Khabour. , "Novel N-substituted aminobenzamide scaffold derivatives targeting the dipeptidyl peptidase-IV enzyme ," Drug Design, Development and Therapy, vol. 2014:8, no. , pp. 129-163, 2014
  • Almaaytah, Ammar, Shadi Tarazi, Fawzi Alsheyab, Qosay Al-Balas, and Tareq L. Mukattash., "Antimicrobial and antibiofilm activity of Mauriporin, a multifunctional scorpion venom peptide.," International Journal of Peptide Research and Therapeutics, vol. 20, no. 4, pp. 397-408, 2014
  • Nizar Mhaidat, Ahmad Alkofahi, Reem Hamouri, Ammar Almaaytah, Ali Shoter, Yazan Haddad and Naseer Alrawi, "Altholactone: A Novel, Selective, and Safe Antitumor Agent," World Journal of Cancer Research, vol. 1, no. , pp. 1-6, 2014
  • Ammar Almaaytah, Shadi Tarazi, Ahmad Abu-Alhaijaa, YaraAltall, Nizar AlShar'i , Khaldon Bodoor, Qosay Al-Balas , "Enhanced antimicrobial activity of AamAP1-Lysine, a novel synthetic peptide analog derived from the scorpion venom peptide AamAP1," Pharmaceuticals, vol. 7, no. 7, pp. 502-516, 2014
  • Ammar Almaaytah, Shadi Tarazi, Mohammad Al-Fandi, Ahmad Abuilhaija, Nizar Al-shar'i, Qosay Al-Balas, Aymen Abu-Awad , "The design and functional characterization of the antimicrobial and antibiofilm activities of BMAP27-Melittin, a rationally designed hybrid peptide," International Journal of Peptide Research and Therapeutics, vol. 21, no. 2, pp. 165-177, 2015
  • Qosay Al-Balas, Mohammad Hassan , Nizar Mhaidat, Ammar Almaaytah , "In Silico Identification of Novel Leukotriene A4 Hydrolase Inhibitors as Potential Anti-Inflammatory Agents.," Jordan Journal of Chemistry, vol. 8, no. 3, pp. 199-211, 2013
  • Ammar Almaaytah, Adan Alnaamneh, Ahmad Abualhaijaa, Nizar Alshari', Qosay Albalas, "In Vitro Synergistic Activities of the Hybrid Antimicrobial Peptide MelitAP-27 in Combination with Conventional Antibiotics Against Planktonic and Biofilm Forming Bacteria," International Journal of Peptide Research and Therapeutics, vol. , no. , pp. 0-0, 2016
  • "A PHARMACEUTICAL GUIDE TO ADALIMUMAB BIOSIMILARS", Farmacia
  • "A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria", Molecules
  • "ANTIMICROBIAL PEPTIDES AS POTENTIAL THERAPEUTICS: ADVANTAGES, CHALLENGES AND RECENT ADVANCES", Farmacia
  • "Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: Biochemical and functional characterization of natural peptides and a single site-substituted analog", Peptides
  • "Biological activities and phenolic contents of Argania spinosa L (Sapotaceae) leaf extract", Tropical Journal of Pharmaceutical Research
  • "Combination of pharmacophore modeling and 3D-QSAR analysis of potential glyoxalase-I inhibitors as anticancer agents", Computational Biology and Chemistry
  • "Computational and experimental exploration of the structure?activity relationships of flavonoids as potent glyoxalase-I inhibitors", Drug Development Research
  • "Design and characterization of a new hybrid peptide from LL-37 and BMAP-27", Infection and Drug Resistance
  • "Development of Novel Ultrashort Antimicrobial Peptide Nanoparticles with Potent Antimicrobial and Antibiofilm Activities against Multidrug Resistant Bacteria", Drug Design, Development and Therapy
  • "Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria", Drug Design, Development and Therapy
  • "Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold", Acta Pharmaceutica
  • "Functional Characterization of a Novel Hybrid Peptide with High Potency against Gram-negative Bacteria", Current Pharmaceutical Design
  • "Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides", Infection and Drug Resistance
  • "INVESTIGATING THE PHYSICOCHEMICAL, NON-CLINICAL, AND CLINICAL CRITERIA FOR ASSESSING COMPARABILITY IN RANIBIZUMAB BIOSIMILARS: A COMPREHENSIVE REVIEW", Farmacia
  • "In vivo antimicrobial activity of the hybrid peptide H4: a follow-up study", Infection and Drug Resistance
  • "Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors", Molecules
  • "Novel Thiazole Carboxylic Acid Derivatives Possessing a ?Zinc Binding Feature? as Potential Human Glyoxalase-I Inhibitors", Letters in Drug Design & Discovery
  • "Oral Delivery of Teriparatide Using a Nanoemulsion System: Design, in Vitro and in Vivo Evaluation", Pharmaceutical Research
  • "Punicalagin and zinc (II) ions inhibit the activity of SARS-CoV-2 3CL-protease in vitro", European Review for Medical and Pharmacological Sciences
  • "Recent Advances in Glyoxalase-I Inhibition", Mini-Reviews in Medicinal Chemistry
  • "Scorpion venom peptides with no disulfide bridges: A review", Peptides
  • "Synergism of cationic antimicrobial peptide WLBU2 with antibacterial agents against biofilms of multi-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae", Infection and Drug Resistance
  • "The Design of Alapropoginine, a Novel Conjugated Ultrashort Antimicrobial Peptide with Potent Synergistic Antimicrobial Activity in Combination with Conventional Antibiotics", Antibiotics
  • "The design and evaluation of the antimicrobial activity of a novel conjugated penta-ultrashort antimicrobial peptide in combination with conventional antibiotics against sensitive and resistant strains of S. aureus and E. coli.", Research in Pharmaceutical Sciences
  • "The design and functional characterization of a novel hybrid antimicrobial peptide from Esculentin-1a and melittin", Pharmacia
  • "The evaluation of the synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with conventional antibiotics against representative resistant strains of both Gram-positive and Gram-negative bacteria", Infection and Drug Resistance
  • Head of the Center, 6, Oct 2023 - Present
  • Dean , Faculty Of Pharmacy, Sep 2023 - Present
  • Head of the Center, 6, Feb 2023 - Oct 2023
  • Head of the Center, Civil Society Development Center, Oct 2022 - Feb 2023
  • Acting Office Director, 0.18, Jan 2018 - Jul 2018
  • Office Director, 0.16, Sep 2017 - Jul 2018
  • Assistant President, University Presidency, Sep 2017 - Jul 2018
  • Director of the Unir, Public relations and media unit, Sep 2016 - Dec 2016
  • Office Director, 0.16, Sep 2016 - Sep 2017
  • Office Director, Alumni Office, Nov 2015 - Nov 2016
  • Deputy Head of Department, Department of Pharmaceutical Technology, Sep 2014 - Sep 2015
  • Assistant Dean, Assistant Dean, Sep 2011 - Sep 2014
  • Faculty Member, Department of Pharmaceutical Technology, Sep 2010 - Present
  • PSR, Pfizer, Jordan, Jun 2006- Jul 2007
  • ADVANCED PHARMACEUTICAL MICROBIOLOGY
  • BASIC MICROBIOLOGY
  • BIO PHARMACEUTICS AND PHARMACOKINETICS
  • DRUG DELIVERY SYSTEMS
  • PHARMACEUTICAL PRACTICAL TRAINING
  • PHARMACEUTICAL BIOTECHNOLOGY
  • PHARMACEUTICAL MICROBIOLOGY
  • PHARMACEUTICAL MICROBIOLOGY AND BIOTECHNOLOGY
  • PHARMACEUTICAL MICROBIOLOGY AND BIOTECHNOLOGY LABORATORY
  • PHARMACEUTICAL MICROBIOLOGY LAB
  • PHARMACEUTICS (4) (FOR PHARM.D STUDENTS)
  • PHARMACY PRACTICE LABORATORY( 2)
  • PROTEIN AND GENE THERAPY
  • RESEARCH METHODOLOGY
  • SELECTED TOPICS ( 1)
  • SELECTED TOPICS ( 2)
  • SEMINAR IN PHARMACEUTICAL TECHNOLOGY
    Technical Paper Reviews
  • Molecular Biology Reports, Journal
  • Artificial Cells, Nanomedicine and Biotechnology, Journal
  • International Journal of Peptide Research and Therapeutics, Journal
  • Mini reviews in Medicinal Chemistry, Journal
  • Peptides, Journal
    Conference Duties
  • 3rd International Meeting on Antimicrobial Peptides, United Kingdom, Panelist
  • The 1st International Conference in Modern advances in the Field of Biotechnology and Genetic Engineering - ICBG2013, Jordan, Session Chair
  • The 3rd Jordanian International Pharmaceutical Conference, Jordan, Key Notes Speaker
  • Antimicrobial peptides: New challenges for science, United Kingdom, Key Notes Speaker
  • The 14th Jordanian Pharmaceutical Conference, Jordan, Key Notes Speaker
  • The 6th Jordanian Scientific Research Conference, Jordan, Key Notes Speaker
  • The 3rd International Conference on Antimicrobial Research, Spain, Key Notes Speaker
  • The Peptides Conference, United Kingdom, Key Notes Speaker
    Professional Memberships
  • European Peptide society, 2011
  • British Pharmacological society, 2011
  • Jordanian Food & Drug Administration - Generic Drugs Advisory Committee, 2013
  • American Peptide Society, 2015